Masimo Debt to Equity Ratio 2010-2024 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending June 30, 2024 was 0.55.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $1.53B $1.37B 1.11
2024-03-31 $1.59B $1.37B 1.17
2023-12-31 $1.68B $1.37B 1.23
2023-09-30 $1.72B $1.28B 1.35
2023-06-30 $1.70B $1.31B 1.30
2023-03-31 $1.79B $1.33B 1.34
2022-12-31 $1.87B $1.34B 1.40
2022-09-30 $1.80B $1.25B 1.44
2022-06-30 $1.76B $1.20B 1.46
2022-03-31 $0.33B $1.58B 0.21
2021-12-31 $0.34B $1.55B 0.22
2021-09-30 $0.30B $1.47B 0.20
2021-06-30 $0.29B $1.39B 0.21
2021-03-31 $0.27B $1.33B 0.20
2020-12-31 $0.31B $1.41B 0.22
2020-09-30 $0.30B $1.42B 0.21
2020-06-30 $0.29B $1.35B 0.22
2020-03-31 $0.22B $1.25B 0.18
2019-12-31 $0.23B $1.17B 0.20
2019-09-30 $0.21B $1.11B 0.19
2019-06-30 $0.19B $1.04B 0.18
2019-03-31 $0.17B $1.01B 0.17
2018-12-31 $0.19B $0.97B 0.19
2018-09-30 $0.18B $0.91B 0.20
2018-06-30 $0.18B $0.83B 0.22
2018-03-31 $0.18B $0.77B 0.24
2017-12-31 $0.18B $0.72B 0.25
2017-09-30 $0.19B $0.72B 0.26
2017-06-30 $0.19B $0.71B 0.26
2017-03-31 $0.24B $0.63B 0.38
2016-12-31 $0.26B $0.56B 0.47
2016-09-30 $0.31B $0.33B 0.92
2016-06-30 $0.31B $0.30B 1.04
2016-03-31 $0.35B $0.27B 1.32
2015-12-31 $0.33B $0.28B 1.18
2015-09-30 $0.31B $0.27B 1.15
2015-06-30 $0.30B $0.28B 1.06
2015-03-31 $0.25B $0.33B 0.77
2014-12-31 $0.26B $0.31B 0.84
2014-09-30 $0.25B $0.28B 0.87
2014-06-30 $0.18B $0.32B 0.56
2014-03-31 $0.11B $0.35B 0.30
2013-12-31 $0.11B $0.33B 0.34
2013-09-30 $0.11B $0.31B 0.36
2013-06-30 $0.10B $0.29B 0.35
2013-03-31 $0.11B $0.28B 0.38
2012-12-31 $0.10B $0.28B 0.36
2012-09-30 $0.10B $0.31B 0.30
2012-06-30 $0.09B $0.30B 0.29
2012-03-31 $0.10B $0.28B 0.37
2011-12-31 $0.09B $0.28B 0.31
2011-09-30 $0.08B $0.30B 0.26
2011-06-30 $0.07B $0.28B 0.26
2011-03-31 $0.07B $0.26B 0.29
2010-12-31 $0.08B $0.23B 0.35
2010-09-30 $0.08B $0.25B 0.32
2010-06-30 $0.07B $0.23B 0.33
2010-03-31 $0.08B $0.21B 0.40
2009-12-31 $0.07B $0.29B 0.23
2009-09-30 $0.07B $0.27B 0.24
2009-06-30 $0.06B $0.25B 0.25
2009-03-31 $0.07B $0.24B 0.29
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.841B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.467B 25.92
Intuitive Surgical (ISRG) United States $180.733B 94.49
Alcon (ALC) Switzerland $45.462B 32.00
Edwards Lifesciences (EW) United States $40.042B 24.90
IQVIA Holdings (IQV) United States $38.149B 21.02
IDEXX Laboratories (IDXX) United States $33.943B 39.97
DexCom (DXCM) United States $27.225B 41.00
Waters (WAT) United States $22.999B 34.01
STERIS (STE) Ireland $22.270B 25.99
SONOVA HOLDING (SONVY) Switzerland $21.961B 0.00
Hologic (HOLX) United States $19.446B 20.52
Fresenius Medical Care AG KGaA (FMS) Germany $11.766B 13.19
Sysmex ADR (SSMXY) Japan $11.599B 36.37
Globus Medical (GMED) United States $10.118B 28.30
Teleflex (TFX) United States $9.629B 15.36
Penumbra (PEN) United States $8.808B 86.28
Glaukos (GKOS) United States $7.219B 0.00
PROCEPT BioRobotics (PRCT) United States $5.065B 0.00
Integer Holdings (ITGR) United States $4.244B 24.06
Inari Medical (NARI) United States $2.865B 0.00
TransMedics (TMDX) United States $2.852B 90.39
Veracyte (VCYT) United States $2.687B 166.57
LivaNova (LIVN) United Kingdom $2.661B 15.36
Nihon Kohden (NHNKY) Japan $2.561B 15.94
Elekta AB (EKTAY) Sweden $2.323B 18.92
Tandem Diabetes Care (TNDM) United States $2.151B 0.00
RxSight (RXST) United States $1.896B 0.00
Integra LifeSciences Holdings (IART) United States $1.871B 9.73
Alphatec Holdings (ATEC) United States $1.185B 0.00
Artivion (AORT) United States $1.150B 105.61
OPKO Health (OPK) United States $1.032B 0.00
Pulse Biosciences (PLSE) United States $0.934B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.883B 15.01
OrthoPediatrics (KIDS) United States $0.696B 0.00
Pacific Biosciences Of California (PACB) United States $0.684B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.662B 0.00
Mesa Laboratories (MLAB) United States $0.641B 16.18
IRadimed (IRMD) United States $0.626B 33.81
AxoGen (AXGN) United States $0.622B 0.00
SiBone (SIBN) United States $0.568B 0.00
Paragon 28 (FNA) United States $0.506B 0.00
CVRx (CVRX) United States $0.365B 0.00
Tactile Systems Technology (TCMD) United States $0.359B 19.62
ClearPoint Neuro (CLPT) United States $0.352B 0.00
Treace Medical Concepts (TMCI) United States $0.338B 0.00
Delcath Systems (DCTH) United States $0.299B 0.00
AngioDynamics (ANGO) United States $0.274B 0.00
Sight Sciences (SGHT) United States $0.234B 0.00
Inogen (INGN) United States $0.214B 0.00
Semler Scientific (SMLR) United States $0.210B 14.62
Nevro (NVRO) United States $0.199B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Accuray (ARAY) United States $0.180B 0.00
Atossa Genetics (ATOS) United States $0.177B 0.00
Alpha Tau Medical (DRTS) Israel $0.156B 0.00
KORU Medical Systems (KRMD) United States $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.122B 0.00
908 Devices (MASS) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.104B 15.51
EDAP TMS S.A (EDAP) France $0.100B 0.00
WORK Medical Technology Group (WOK) China $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Precision Optics (POCI) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Baird Medical Investment Holdings (BDMD) $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
T2 Biosystems (TTOO) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00